PACWEST BANCORP (PACW)

US6952631033 - Common Stock

7.54  -0.21 (-2.71%)

After market: 7.6 +0.06 (+0.8%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PACW. PACW was compared to 412 industry peers in the Banks industry. PACW may be in some trouble as it scores bad on both profitability and health. PACW has a valuation in line with the averages, but on the other hand it scores bad on growth.



2

1. Profitability

1.1 Basic Checks

PACW had positive earnings in the past year.
In the past year PACW had a positive cash flow from operations.
Of the past 5 years PACW 4 years were profitable.
PACW had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.27%, PACW is doing worse than 99.52% of the companies in the same industry.
PACW has a worse Return On Equity (-49.51%) than 99.52% of its industry peers.
Industry RankSector Rank
ROA -3.27%
ROE -49.51%
ROIC N/A
ROA(3y)-0.59%
ROA(5y)0.35%
ROE(3y)-3.17%
ROE(5y)1.88%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PACW's Profit Margin has declined in the last couple of years.
PACW does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.15%
PM growth 5Y-1.85%
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

PACW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PACW remains at a similar level compared to 1 year ago.
PACW has less shares outstanding than it did 5 years ago.
PACW has a worse debt/assets ratio than last year.

2.2 Solvency

PACW has a debt to FCF ratio of 18.17. This is a negative value and a sign of low solvency as PACW would need 18.17 years to pay back of all of its debts.
With a Debt to FCF ratio value of 18.17, PACW is not doing good in the industry: 83.93% of the companies in the same industry are doing better.
A Debt/Equity ratio of 2.85 is on the high side and indicates that PACW has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.85, PACW is doing worse than 95.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF 18.17
Altman-Z N/A
ROIC/WACCN/A
WACC11.75%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

1

3. Growth

3.1 Past

The earnings per share for PACW have decreased strongly by -44.42% in the last year.
PACW shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.05% yearly.
Looking at the last year, PACW shows a very negative growth in Revenue. The Revenue has decreased by -23.40% in the last year.
The Revenue has been growing slightly by 4.27% on average over the past years.
EPS 1Y (TTM)-44.42%
EPS 3Y-1.79%
EPS 5Y4.05%
EPS growth Q2Q-78.43%
Revenue 1Y (TTM)-23.4%
Revenue growth 3Y5.67%
Revenue growth 5Y4.27%
Revenue growth Q2Q-83.81%

3.2 Future

The Earnings Per Share is expected to decrease by -46.83% on average over the next years. This is quite bad
PACW is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.73% yearly.
EPS Next Y-87.54%
EPS Next 2Y-52.48%
EPS Next 3Y-46.83%
EPS Next 5YN/A
Revenue Next Year-45.69%
Revenue Next 2Y-18.18%
Revenue Next 3Y-16.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.13, the valuation of PACW can be described as very cheap.
98.32% of the companies in the same industry are more expensive than PACW, based on the Price/Earnings ratio.
PACW is valuated cheaply when we compare the Price/Earnings ratio to 24.80, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.37, which indicates a very decent valuation of PACW.
Based on the Price/Forward Earnings ratio, PACW is valued a bit cheaper than the industry average as 69.54% of the companies are valued more expensively.
PACW's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.27.
Industry RankSector Rank
PE 3.13
Fwd PE 9.37

4.2 Price Multiples

96.88% of the companies in the same industry are more expensive than PACW, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.25
EV/EBITDA N/A

4.3 Compensation for Growth

PACW's earnings are expected to decrease with -46.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.77
EPS Next 2Y-52.48%
EPS Next 3Y-46.83%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.53%, PACW is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.91, PACW's dividend is way lower than its industry peers. On top of this 86.57% of the companies listed in the same industry pay a better dividend than PACW!
With a Dividend Yield of 0.53, PACW pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

The dividend of PACW decreases each year by -10.10%.
PACW has been paying a dividend for at least 10 years, so it has a reliable track record.
PACW has decreased its dividend recently.
Dividend Growth(5Y)-10.1%
Div Incr Years0
Div Non Decr Years1

5.3 Sustainability

The earnings of PACW are negative and hence is the payout ratio. PACW will probably not be able to sustain this dividend level.
PACW's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-10.37%
EPS Next 2Y-52.48%
EPS Next 3Y-46.83%

PACWEST BANCORP

NASDAQ:PACW (11/30/2023, 7:16:12 PM)

After market: 7.6 +0.06 (+0.8%)

7.54

-0.21 (-2.71%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap894.17M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 3.13
Fwd PE 9.37
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.77
Profitability
Industry RankSector Rank
ROA -3.27%
ROE -49.51%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-44.42%
EPS 3Y-1.79%
EPS 5Y
EPS growth Q2Q
EPS Next Y-87.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-23.4%
Revenue growth 3Y5.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y